Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Inventory (2022 - 2023)

Silence Therapeutics' Inventory history spans 2 years, with the latest figure at $483772.8 for Q1 2023.

  • On a quarterly basis, Inventory changed N/A to $483772.8 in Q1 2023 year-over-year; TTM through Mar 2023 was $483772.8, a N/A change, with the full-year FY2022 number at $551973.7, changed N/A from a year prior.
  • Inventory hit $483772.8 in Q1 2023 for Silence Therapeutics, down from $523126.0 in the prior quarter.
  • Over the last five years, Inventory for SLN hit a ceiling of $523126.0 in Q4 2022 and a floor of $483772.8 in Q1 2023.